It’s complicated. HER2-positive breast cancer is more likely to grow and spread quickly, but additional targeted therapies are available to treat it.
Meanwhile, HER2-negative breast cancer tends to grow more slowly but can have fewer available treatment options, especially in the case of triple-negative breast cancer.